Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis
Status:
Recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
This is a phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-group
study in patients with moderate to severe active ulcerative colitis.